{
    "2019-12-18": [
        [
            {
                "time": "",
                "orginal_text": "1日8日晚间公告精选丨中国动力实施百亿重组获通过；绿庭投资、环旭电子等提示风险",
                "features": {
                    "keywords": [
                        "中国动力",
                        "百亿重组",
                        "绿庭投资",
                        "环旭电子",
                        "风险提示"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "军工",
                        "电子",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "乐普医疗(300003.SZ)：7.5亿元可转债计划获批",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "可转债",
                        "7.5亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "渤海证券：政策多变下积极布局医药核心资产",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "政策多变",
                        "医药核心资产"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "2019十大最受机构关注个股 海康威视位列首位",
                "features": {
                    "keywords": [
                        "2019",
                        "机构关注",
                        "海康威视"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "安防"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "【民生医药|公司深度】复星医药：整合能力提升+创新增量催化，业绩迎来兑现期",
                "features": {
                    "keywords": [
                        "复星医药",
                        "整合能力",
                        "创新增量",
                        "业绩兑现"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}